ImmuCell Corp (NASDAQ:ICCC)

7.11
Delayed Data
As of Apr 26
 -0.2056 / -2.81%
Today’s Change
5.26
Today|||52-Week Range
9.25
-19.11%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.32
Today’s open7.11
Day’s range7.11 - 7.11
Volume1,234
Average volume (3 months)9,530
Market cap$36.8M
Data as of 2:51pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+9.29%
P/E ratioNM
Price/Sales4.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.01-2.61%
APVOAptevo Therapeutics ...+0.22+5.21%
BPTHBio Path Holdings In...0.000.00%
CANFCan Fite Biopharma L...0.000.00%
Data as of 8:00pm ET, 04/26/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$10.4M
Annual profit (last year)-$168.0K
Net profit margin-1.61%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts